---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 21, 2004

 

---

 

PharmaNetics, Inc.

(Exact name of registrant as specified in its charter)

 

---

 

North Carolina

(State or other jurisdiction of incorporation)

 

0-25133		56-2098302
(Commission file Number)		(IRS Employer ID Number)

 

9401 Globe Center Drive, Morrisville, North Carolina 27560

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code 919-582-2600

 

NA

(Former name or former address, if changed since last report)

 

---

---

Item 5. Other Events.

 

On April 21, 2004, PharmaNetics (the “Registrant”) issued a press release which is attached to this report as Exhibit 99.1, and is incorporated herein in its entirety by reference.

 

Item 7. Financial Statements and Exhibits

 

(c) Exhibits

 

99.1		Press release dated April 21, 2004 announcing that the Registrant filed its Annual Report on Form 10-K for the year ended December 31, 2003 on April 14, 2004 and that the financial statements as of and for the year ended December 31, 2003 contained a going-concern qualification from its auditors.

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

		PHARMANETICS, INC.
Date: April 22, 2004		/s/ Paul T. Storey
		Paul T. Storey
		Chief Financial Officer